Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
OverviewMechanism of ActionHow To UseUsesBenfitsIndicationsMethod of AdministrationDosage StrengthsDosage FormsDietary RestrictionsContraindicationsAdverse ReactionsSide EffectsUse of Meticillin in Specific PopulationsClinical Pharmacology Authored by Reviewed by References
Meticillin

Meticillin

Indications, Uses, Dosage, Drugs Interactions, Side effects
Meticillin
Medicine Type :
Allopathy
Prescription Type:
Prescription Required
Pharmacological Class:
Beta lactam Antibiotics,
Therapy Class:
Antibiotic,

Meticillin belongs to the pharmacological class of Beta-Lactam Antibiotics.

Meticillin has been approved to relieve symptoms and also for the treatment and maintenance of susceptible infections, respiratory tract infections, abdominal infections, skin, and soft tissue infections, pelvic infections, bacterial endocarditis, peritonitis, septicemia, biliary tract infections, prophylaxis of infection during surgery, uncomplicated gonorrhea, uncomplicated urinary tract infections.

Meticillin undergoes hepatic metabolism by 20-40%

The common side effects involving the use of Meticillin are fever, chills, sweating, tachycardia, hyperventilation, flushing, and myalgia.

Meticillin is available in the form of Intramuscular and Intravenous solutions.

Meticillin is available in the U.S., Italy, Germany, Austria, France, Israel, and Brazil.

Meticillin belongs to the pharmacological class of Beta-Lactam Antibiotics.

Meticillin binds to and inhibits penicillin-binding proteins (PBPs). Meticillin binds to specific penicillin-binding proteins (PBPs), which are located inside the bacterial cell wall. Meticillin is said to inhibit the third and last stage of bacterial cell wall synthesis. Hence, the Cell lysis is then mediated by the bacterial cell wall autolytic enzymes such as autolysins.

Meticillin has been approved to relieve symptoms and also for the treatment and maintenance of infections caused by the susceptible Gram-positive bacteria, which particularly include beta-lactamase-producing organisms such as Staphylococcus aureus that would otherwise be resistant to most penicillins.

Meticillin is available in the form of Intramuscular and Intravenous.

Meticillin can be used in the following treatment:

  • Infections are caused by susceptible Gram-positive bacteria, which particularly include beta-lactamase-producing organisms such as Staphylococcus aureus that is otherwise be resistant to most penicillins.

Meticillin can help to relieve symptoms and also for the treatment and maintenance of infections caused by susceptible Gram-positive bacteria, which particularly include beta-lactamase-producing organisms such as Staphylococcus aureus that is otherwise be resistant to most penicillins.

Meticillin is approved for use in the following clinical indications:

  • Infections are caused by susceptible Gram-positive bacteria, which particularly include beta-lactamase-producing organisms such as Staphylococcus aureus that is otherwise be resistant to most penicillins.

Intramuscular or Intravenous: To be administered by the registered medical practitioner.

Susceptible infections, Respiratory tract infections, Abdominal infections, skin, and soft tissue infections, Pelvic infections, Bacterial endocarditis, Peritonitis, Septicaemia, Biliary tract infections

Serious infections: 200-300 mg/kg/day in divided doses. Life-threatening infections: Up to 350 mg/kg/day. Max: 24 g/day.

Prophylaxis of infection during surgery

Adult: 4 g preoperatively, followed by two further doses every 6 hr.

Uncomplicated gonorrhea

Adult: 1-2 g Intramuscular or Intravenous as a single dose. Probenecid 1 g may be given orally at the same time or up to 30 min before the injection.

Uncomplicated urinary tract infections

Adult: 1.5-2 g Intramuscular or Intravenous every 6 hr.

250 mg , 500mg tablets

Intramuscular and Intravenous.

  • Dosage Adjustments in Kidney Patients:

Mild renal failure: GFR > 50 mL/min: normal dose every 4 to 6 hours

Moderate renal failure: GFR 10 to 50 mL/min: normal dose every 6 to 8 hours

Severe renal failure: GFR < 10 mL/min: normal dose every 8 to 12 hours.

  • Dosage Adjustments in Hepatic Impairment Patients:

No dosage adjustments are needed for hepatic Impairment.

  • Dosage Adjustments in Pediatric Patients:

Neonates less than seven days of age, 50-75 mg/kg/day Intramuscular / Intravenous divided every 8-12 hr

Neonates 7 days of age and older, 75-100 mg/kg/day Intramuscular / Intravenous. divided every 6-8 hr

Infants and children, 100-200 mg/kg/day IV/IM divided every 6 hr; maximum 12 g/day.

Avoid high-acid foods like citrus fruits and juices like orange and grapefruit, soda, and chocolates.

Alcohol intake might lead to nausea, vomiting, and headache

Mult Intravenous vitamins and antacids contain minerals, primarily magnesium, calcium, aluminum, iron, or zinc, which bind to the antibiotic and refrain it from working. Spacing them at least for 2 hours after Meticillin administration is recommended.

Meticillin may is contraindicated under the following conditions:

  • Patients with known hypersensitivity to penicillins.

The adverse reactions related to Meticillin can be categorized as follows:

  • Thrombocytopenia
  • Seizures
  • Interstitial nephritis
  • Nephrotoxicity
  • Neutropenia
  • Inhibition of platelet aggregation
  • Transient increases in transaminases
  • Thrombophlebitis
  • Jarisch-Herxheimer Reaction (fever, chills, sweating, tachycardia, hyperventilation, flushing, and myalgia).

The clinically relevant drug interactions of Meticillin are briefly summarized here:

  • Probenecid may inhibit renal excretion of Meticillin. Monitor blood coagulation parameters when used with high-dose heparin and other anticoagulants.

The following are the side effects involving Meticillin:

  • Thrombocytopenia
  • Seizures
  • Interstitial nephritis
  • Nephrotoxicity
  • neutropenia
  • Inhibition of platelet aggregation
  • Transient increases in transaminases
  • Thrombophlebitis
  • Jarisch-Herxheimer Reaction (fever, chills, sweating, tachycardia, hyperventilation, flushing, and myalgia).

Pregnancy

Category B: No evidence of risk in humans but studies inadequate.

Pharmacodynamics

Meticillin (INN, BAN) or methicillin (USAN) is a narrow-spectrum beta-lactam antibiotic of the penicillin class. It is no longer clinically used. Its role in therapy has been largely replaced by flucloxacillin and dicloxacillin, however, the term methicillin-resistant Staphylococcus aureus (MRSA) continues to be used to describe Staphylococcus aureus strains resistant to all penicillins.

Pharmacokinetics

  • Absorption:

N.A.

  • Distribution:

N.A.

  • Metabolism:

Meticillin undergoes hepatic metabolism of about 20-40%

  • Excretion:

N.A.

  • https://wikem.org/wiki/Methicillin
  • https://www.drugs.com/pregnancy/methicillin.html
  • https://www.britannica.com/science/methicillin
  • http://antimicrobe.org/drugpopup/methicillin.htm
  • https://pubchem.ncbi.nlm.nih.gov/compound/Methicillin-sodium
  • https://go.drugbank.com/drugs/DB01603
undefined
Sonali R Muralidhar
I am Sonali R Muralidhar currently residing at Madurai.I have completed my Master’s in Pharmacy with my core subject as Pharmaceutics. I am interested in Pharmaceutical research , medical content writing, Biopharmaceutics , regulatory affairs , novel drug delivery, targeted drug delivery.
undefined
Dr JUHI SINGLA
Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Published on: 21 March 2023 6:28 PM GMT
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok